香港股市 已收市

朝聚眼科 (2219.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
3.960+0.140 (+3.66%)
收市:04:08PM HKT

朝聚眼科

Shouke Building
Block A, 24th Floor East Zone, Fengtai District No. 14 Yard, West 3rd Ring South Road
Beijing
China

https://www.chaojueye.com

版塊Healthcare
行業Medical Care Facilities
全職員工2,597

高階主管

名稱頭銜支付行使價出生年份
Mr. Bozhou ZhangChairman & CEO1.27M1963
Ms. Xiaoli ZhangExecutive Director1.43M1962
Mr. Guangdi ZhangExecutive Director673.57k1994
Mr. Junfeng ZhangExecutive Director406.95k1967
Mr. Jin FuChief Financial Officer1983
Mr. Hongyan LiuChief Operating Officer1971
Ms. Yajun YangChief Medical Officer1972
Mr. Ching Kit Cheng A.C.I.S., A.C.S.Joint Company Secretary1989
Ms. Chun XieJoint Company Secretary1982
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides basic ophthalmic services, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases. In addition, it sells eyewear, equipment, and optical products. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.

公司管治

截至 無 止,朝聚眼科 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。